Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: A prospective follow-up study.
[esophageal adenocarcinoma]
Barrett
's
esophagus
(
BE
)
goes
through
a
sequence
of
low
grade
dysplasia
(
LGD
)
and
high
grade
dysplasia
(
HGD
)
to
esophageal
adenocarcinoma
(
EAC
)
.
The
current
gold
standard
for
BE
outcome
prediction
,
histopathological
staging
,
can
be
unreliable
.
TP
53
abnormalities
may
serve
as
prognostic
biomarkers
.
TP
53
protein
accumulation
detected
by
immunohistochemistry
(
IHC
)
indirectly
assesses
TP
53
mutations
.
DNA
fluorescent
in
situ
hybridization
(
FISH
)
on
brush
cytology
specimens
directly
evaluates
gene
locus
loss
.
We
evaluated
if
IHC
and
FISH
are
complementary
tools
to
assess
TP
53
abnormalities
and
tested
their
prognostic
value
in
a
long
-term
prospective
follow-up
of
a
BE
cohort
.
TP
53
IHC
on
tissue
sections
and
FISH
on
brush
cytology
specimens
were
evaluated
for
116
BE
patients
with
respect
to
the
different
histological
stages
.
The
TP
53
abnormalities
were
further
studied
in
a
panel
of
cell
lines
representative
of
the
Barrett
's
carcinogenic
sequence
.
For
91
patients
,
the
predictive
value
of
TP
53
abnormalities
with
respect
to
progression
to
HGD
/
EAC
was
tested
after
long
term
follow-up
.
The
frequency
of
IHC
and
FISH
TP
53
abnormalities
increased
significantly
with
increasing
histological
stage
(
P
 
<
 
0
.
001
,
Chi
(
2
)
-
test
)
.
Combining
the
techniques
detected
TP
53
abnormalities
in
100
%
of
patients
with
LGD
,
HGD
,
and
EAC
.
Multivariate
analysis
showed
that
IHC
(
hazard
ratio
:
17
,
95
%
CI
:
3
.
2
-
96
,
P
 
=
 
0
.
001
)
and
FISH
(
hazard
ratio
:
7
.
3
,
95
%
CI
:
1
.
3
-
41
,
P
 
=
 
0
.
02
)
were
both
independent
significant
predictors
of
progression
.
Combining
FISH
and
IHC
in
assessing
TP
53
abnormalities
leads
to
an
increased
detection
rate
of
TP
53
aberrations
and
improved
accuracy
for
predicting
BE
progression
.
©
2014
Wiley
Periodicals
,
Inc
.
Diseases
Validation
Diseases presenting
"low grade dysplasia"
symptom
esophageal adenocarcinoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom